|
16.06.2014 19:09:00
|
Medtronic, Inc. -- Moody's affirms Medtronic's A2 rating on news of planned Covidien acquisition
New York, June 16, 2014 -- Moody's Investors Service affirmed the ratings of Medtronic, Inc. following its announcement that it plans to acquire Covidien plc (debt rated at Covidien International Finance S.A.) for about $42.9 billion. Medtronic expects the transaction to close in late 2014 or early 2015, subject to regulatory and shareholder approvals. The rating outlook is stable.
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.